Average Co-Inventor Count = 2.00
ph-index = 19
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Esperion Therapeutics, Inc. (30 from 60 patents)
2. Gemphire Therapeutics Inc. (1 from 4 patents)
31 patents:
1. 10941095 - Hydroxyl compounds and compositions for cholesterol management and related uses
2. 10227285 - Processes and intermediates for preparing alpha,omega-dicarboxylic acid-terminated dialkane ethers
3. 10118881 - Hydroxyl compounds and compositions for cholesterol management and related uses
4. 10047028 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
5. 9624152 - Hydroxyl compounds and compositions for cholesterol management and related uses
6. 9452964 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
7. 9006290 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
8. 9000041 - Hydroxyl compounds and compositions for cholesterol management and related uses
9. 8975300 - Ketone compounds and compositions for cholesterol management and related uses
10. 8642653 - Ketone compounds and compositions for cholesterol management and related uses
11. 8623915 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
12. 8497301 - Hydroxyl compounds and compositions for cholesterol management and related uses
13. 8309604 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
14. 8153690 - Cycloalkyl-hydroxyl compounds and compositions for cholesterol management
15. 7838554 - Dihydroxyl compounds and compositions for cholesterol management and related uses